WORKING TOGETHER TO OFFER MORE CANCER PATIENTS A BETTER QUALITY OF LIFE

IBA, one of the driving forces of proton therapy as a cancer treatment modality, firmly believes that collaborative efforts generate the most meaningful and ingenious ideas to protect, enhance and save more lives. Fostering a unique, open culture of sharing, IBA consults peers and sets up collaborations with diverse proton therapy stakeholders to support its primary mission: making proton therapy accessible to all patients who can benefit from it. Involving customers, renowned scientific centers and industry players, IBA provides frameworks to support these different parties in setting up joint investigations. These efforts are driven by a triple objective: make proton therapy more affordable, extend the scope of clinical indications eligible for proton therapy, and target technological excellence.

To read more about the IBA approach to research collaborations, including compelling examples and testimonials: